Filing Details
- Accession Number:
- 0001640455-21-000074
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-16 20:46:34
- Reporting Period:
- 2021-04-15
- Accepted Time:
- 2021-04-16 20:46:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640455 | Jounce Therapeutics Inc. | JNCE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1581954 | Duncan John Higgons | C/O Jounce Therapeutics, Inc. 780 Memorial Drive Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-15 | 200 | $10.00 | 9,713 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2020. The Reporting Person exercised no discretion with respect to this transaction.
Billionaire Hedge Funds
